Pharmaceutical care for a case of infective endocarditis caused by <italic style="font-style: italic">Micrococcus luteus</italic> complicated with severe pneumonia

WANG Siyun; CHEN Junjun; ZHU Yuhui; LI Xin; ZHANG Xinru

doi:10.6039/j.issn.1001-0408.2023.09.21

您当前的位置：

首页 >

文章列表页 >

Pharmaceutical care for a case of infective endocarditis caused by Micrococcus luteus complicated with severe pneumonia

更新时间：2025-09-23

- Pharmaceutical care for a case of infective endocarditis caused by Micrococcus luteus complicated with severe pneumonia
- ZHONGGUO YAOFANG Vol. 34, Issue 9, Pages: 1137-1141(2023)
- 作者机构：
  
  吉林大学第二医院药学部，长春　130041
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2023.09.21
  CLC： R969.3
- Received：30 January 2023，
  
  Revised：2023-02-12，
  
  Accepted：03 April 2023，
  
  Published：15 May 2023
- 稿件说明：
移动端阅览
王司允,陈俊俊,朱玉辉,等.1例藤黄微球菌致感染性心内膜炎合并重症肺炎的药学监护 [J].中国药房,2023,34(09):1137-1141.

WANG Siyun,CHEN Junjun,ZHU Yuhui,et al.Pharmaceutical care for a case of infective endocarditis caused by Micrococcus luteus complicated with severe pneumonia[J].ZHONGGUO YAOFANG,2023,34(09):1137-1141.
王司允,陈俊俊,朱玉辉,等.1例藤黄微球菌致感染性心内膜炎合并重症肺炎的药学监护 [J].中国药房,2023,34(09):1137-1141. DOI： 10.6039/j.issn.1001-0408.2023.09.21.

WANG Siyun,CHEN Junjun,ZHU Yuhui,et al.Pharmaceutical care for a case of infective endocarditis caused by Micrococcus luteus complicated with severe pneumonia[J].ZHONGGUO YAOFANG,2023,34(09):1137-1141. DOI： 10.6039/j.issn.1001-0408.2023.09.21.

摘要

目的

为藤黄微球菌致感染性心内膜炎（IE）合并重症肺炎的抗感染药物治疗及药学监护提供思路和用药参考。

方法

临床药师全程参与1例藤黄微球菌致IE合并重症肺炎患者的治疗过程，所有抗感染治疗方案与调整均为临床医师邀请临床药师会诊后共同协商确定。方案实施后由临床药师从最适宜治疗药物、利用稳态谷浓度和内生肌酐清除率等参数调整万古霉素剂量、监测肾功能及药物不良反应等方面对治疗的有效性和安全性进行药学监护。

结果

藤黄微球菌致IE患者经手术和术后足疗程的抗菌药物治疗后治愈，重症肺炎好转，原发病及治疗药物引起的肾功能下降有所恢复；临床药师通过协助临床医师制定治疗方案、实施药学监护，保证了患者抗感染治疗的效果，避免了患者进一步的肾损伤，解决了头孢哌酮舒巴坦药物热的问题。

结论

藤黄微球菌致IE病情较重，可选万古霉素联合利福平治疗，治疗过程中应注意监测患者的肾功能，及时调整万古霉素剂量或更换药物；临床药师提供的抗感染药学监护，保障了患者抗感染治疗的有效性和安全性，避免了严重不良反应的发生。

Abstract

OBJECTIVE

To provide ideas and reference for the treatment and pharmaceutical care of infective endocarditis （IE） caused by

Micrococcus luteus

complicated with severe pneumonia.

METHODS

The clinical pharmacist participated in the treatment of a patient with IE caused by

M. luteus

complicated with severe pneumonia； all anti-infect

ive treatment plans were agreed upon after the doctor invited the clinical pharmacist for consultation. After the implementation of the plan， the clinical pharmacist conducted pharmaceutical care of effectiveness and safety for the plan， including adopting suitable drug， adjusting the dose of vancomycin by using parameters such as steady-state valley concentration and creatinine clearance rate， monitoring renal function and adverse drug reactions.

RESULTS

IE caused by

M. luteus

was cured after surgery and full treatment with anti-bacterial drugs， the severe pneumonia was improved， and the decline of renal function caused by drugs and the primary disease were recovered； clinical pharmacists had ensured the effect of anti-infection treatment by assisting in the formulation of treatment plans and the implementation of pharmaceutical care， avoiding further renal damage and solving the problem of cefoperazone sulbactam-related drug fever.

CONCLUSIONS

IE caused by

M. luteus

is relatively serious， and the treatment drug can be vancomycin and rifampicin. During the treatment， it is necessary to monitor the renal function， and adjust the dose of vancomycin or change other drugs； anti-infection pharmaceutical care provided by clinical pharmacists can guarantee the effectiveness and safety of anti-infection plan， and avoid the occurrence of severe adverse drug reactions.

关键词

Keywords

references

DÜRST U N ， BRUDER E ， EGLOFF L ， et al . Micrococcus luteus ：a rare pathogen of valve prosthesis endocarditis [J ] . Z Kardiol ， 1991 ， 80 （ 4 ）： 294 - 298 .

USÓ J ， GIL M ， GOMILA B ， et al . Endocarditis due to Micrococcus luteus [J ] . Enferm Infecc Microbiol Clin ， 2003 ， 21 （ 2 ）： 116 - 117 .

KHAN A ， AUNG T ， CHAUDHURI D . The first case of native mitral valve endocarditis due to Micrococcus luteus and review of the literature [J ] . Case Rep Cardiol ， 2019 ， 2019 ： 5907319 .

SEIFERT H ， KHEUNER M ， PERDREAU-REMINGTON F . Micrococcus luteus endocarditis：case report and review of the literature [J ] . Zentralbl Bakteriol ， 1995 ， 282 （ 4 ）： 431 - 435 .

MARTÍN GUERRA J M ， MARTÍN ASENJO M ， RODRÍGUEZ MARTÍN C . Bacteraemia by Micrococcus luteus in an inmunocompromised patient [J ] . Med Clin （Barc）， 2019 ， 152 （ 11 ）： 469 - 470 .

IANNIELLO N M ， ANDRADE D C ， IVANCIC S ， et al . Native valve infective endocarditis due to Micrococcus luteus in a non-Hodgkin’s lymphoma patient [J ] . IDCases ， 2019 ， 18 ： e00657 .

MILTIADOUS G ， ELISAF M . Native valve endocarditis due to Micrococcus luteus ：a case report and review of the literature [J ] . J Med Case Rep ， 2011 ， 5 ： 251 .

KALIL A C ， METERSKY M L ， KLOMPAS M ， et al . Executive summary：management of adults with hospital-acquired and ventilator-associated pneumonia：2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society [J ] . Clin Infect Dis ， 2016 ， 63 （ 5 ）： 575 - 582 .

中华医学会呼吸病学分会感染学组 . 中国成人医院获得性肺炎与呼吸机相关性肺炎诊断和治疗指南：2018年版 [J ] . 中华结核和呼吸杂志， 2018 ， 41 （ 4 ）： 255 - 280 .

梁峰，胡大一，方全，等 . 2015年欧洲心脏病学会关于感染性心内膜炎并发症治疗的指南解读 [J ] . 中国循证心血管医学杂志， 2017 ， 9 （ 5 ）： 513 - 517 .

HE N ， SU S ， YE Z K ， et al . Evidence-based guideline for therapeutic drug monitoring of vancomycin：2020 update by the division of therapeutic drug monitoring，Chinese Pharmacological Society [J ] . Clin Infect Dis ， 2020 ， 71 （ Suppl 4 ）： S363 - S371 .

何志超，伍俊妍，邱凯锋 . 万古霉素个体化给药临床药师指引 [J ] . 今日药学， 2015 ， 25 （ 2 ）： 78 - 82 .

周铎 . 抗菌药物相关性药物热的临床诊断与治疗 [J ] . 医药导报， 2015 ， 34 （ 1 ）： 50 - 52 .

王东晓，莫昕莹，管希周，等 . 1例抗菌药物相关药物热患者的药学监护 [J ] . 中国药物应用与监测， 2022 ， 19 （ 1 ）： 27 - 29，46 .

杨越，白延宁，张媛媛，等 . 323例抗菌药物致药物热的文献计量研究 [J ] . 实用药物与临床， 2021 ， 24 （ 8 ）： 722 - 726 .

Views

208

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

One case report and literature review of severe cardiotoxicity by oxaliplatin combined with capecitabine

Pharmaceutical care in a patient with hemorrhagic transformation after cerebral infarction complicated with atrial fibrillation

Pharmaceutical care of reactivating anthracycline chemotherapy in a patient with advanced breast cancer combined with thyroid cancer

Prospective cohort study on clinical pharmacist involvement in the management of opioid use after orthopedic surgery under the enhanced recovery after surgery model

Pharmaceutical care for a patient with rhino-orbito-cerebral mucormycosis

Related Author

XU Lina

FANG Yingli

WANG Xiangling

DU Pengcheng

GAO Ling

YUAN Jing

QIN Wenjie

ZHU Bin

Related Institution

Dept. of Oncology， Qilu Hospital of Shandong University

Dept. of Clinical Pharmacy， Dezhou Hospital， Qilu Hospital of Shandong University

Dept. of Clinical Pharmacy， Qilu Hospital of Shandong University

Dept. of Pharmacy， the Hospital of Joint Logistics Support Force

Dept. of Pharmacy， Hunan Provincial People’s Hospital

⁰

Pharmaceutical care for a case of infective endocarditis caused by Micrococcus luteus complicated with severe pneumonia

DOI：10.6039/j.issn.1001-0408.2023.09.21

摘要

Abstract

关键词

Keywords

references